Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aaron King

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
Chemical Society Reviews|November 4, 2017
Quinone-based fluorophores for imaging biological processesGleiston G Dias, Aaron King, Fabio de Moliner, et al.
International Journal of Human-Computer Studies|September 26, 2017
Understanding the Potential of PARO for Healthy Older AdultsSean A McGlynn, Shawn Kemple, Tracy L Mitzner, et al.
American Journal of Preventive Cardiology|February 3, 2025
Effect of glucagon-like peptide-1 receptor agonists on vascular risk factors among adults with type 2 diabetes and established atherosclerotic cardiovascular diseaseAaron King, Xi Tan, Neil Dhopeshwarkar, et al.
Photochemical & Photobiological Sciences : Official Journal of the European Photochemistry Association and the European Society for Photobiology|April 16, 2024
The contradictory role of febuxostat in ABCG2 expression and potentiating hypericin-mediated photodynamic therapy in colorectal cancersAaron King, Thomas Maisey, Erica L Harris, et al.
BMJ Open Diabetes Research & Care|October 4, 2024
Recent trends in GLP-1 RA and SGLT2i use among people with type 2 diabetes and atherosclerotic cardiovascular disease in the USAAaron King, Xi Tan, Neil Dhopeshwarkar, et al.
American Journal of Physiology. Cell Physiology|May 8, 2023
Strategic outline of interventions targeting extracellular matrix for promoting healthy longevityJi Young Cecilia Park, Aaron King, Victor Björk, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|March 27, 2025
Once-Weekly Semaglutide Versus Sodium-Glucose Co-transporter 2 Inhibitors: Real-World Impact on Weight, HbA1c, and Healthcare Resource Utilization in Type 2 Diabetes (PAUSE)James Amamoo, Riddhi Doshi, Joshua Noone, et al.
Postgraduate Medicine|June 12, 2014
A short-acting GLP-1 analog or prandial insulin to supplement basal insulin?--Moving toward personalized management of type 2 diabetes mellitusIrl B Hirsch, Doron Schneider, Aaron King, et al.
Frontiers in Chemistry|August 29, 2018
Quinone-Derived π-Extended Phenazines as New Fluorogenic Probes for Live-Cell Imaging of Lipid DropletsFabio de Moliner, Aaron King, Gleiston G Dias, et al.
Journal of Drugs in Dermatology : JDD|March 15, 2018
Clinical Insights About Onychomycosis and Its Treatment: A ConsensusSam Hanna, Anneke Andriessen, Jennifer Beecker, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Chemical Society Reviews|November 4, 2017
Quinone-based fluorophores for imaging biological processesGleiston G Dias, Aaron King, Fabio de Moliner, et al.
International Journal of Human-Computer Studies|September 26, 2017
Understanding the Potential of PARO for Healthy Older AdultsSean A McGlynn, Shawn Kemple, Tracy L Mitzner, et al.
American Journal of Preventive Cardiology|February 3, 2025
Effect of glucagon-like peptide-1 receptor agonists on vascular risk factors among adults with type 2 diabetes and established atherosclerotic cardiovascular diseaseAaron King, Xi Tan, Neil Dhopeshwarkar, et al.
Photochemical & Photobiological Sciences : Official Journal of the European Photochemistry Association and the European Society for Photobiology|April 16, 2024
The contradictory role of febuxostat in ABCG2 expression and potentiating hypericin-mediated photodynamic therapy in colorectal cancersAaron King, Thomas Maisey, Erica L Harris, et al.
BMJ Open Diabetes Research & Care|October 4, 2024
Recent trends in GLP-1 RA and SGLT2i use among people with type 2 diabetes and atherosclerotic cardiovascular disease in the USAAaron King, Xi Tan, Neil Dhopeshwarkar, et al.
American Journal of Physiology. Cell Physiology|May 8, 2023
Strategic outline of interventions targeting extracellular matrix for promoting healthy longevityJi Young Cecilia Park, Aaron King, Victor Björk, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|March 27, 2025
Once-Weekly Semaglutide Versus Sodium-Glucose Co-transporter 2 Inhibitors: Real-World Impact on Weight, HbA1c, and Healthcare Resource Utilization in Type 2 Diabetes (PAUSE)James Amamoo, Riddhi Doshi, Joshua Noone, et al.
Postgraduate Medicine|June 12, 2014
A short-acting GLP-1 analog or prandial insulin to supplement basal insulin?--Moving toward personalized management of type 2 diabetes mellitusIrl B Hirsch, Doron Schneider, Aaron King, et al.
Frontiers in Chemistry|August 29, 2018
Quinone-Derived π-Extended Phenazines as New Fluorogenic Probes for Live-Cell Imaging of Lipid DropletsFabio de Moliner, Aaron King, Gleiston G Dias, et al.
Journal of Drugs in Dermatology : JDD|March 15, 2018
Clinical Insights About Onychomycosis and Its Treatment: A ConsensusSam Hanna, Anneke Andriessen, Jennifer Beecker, et al.
Pageof 3